38 related articles for article (PubMed ID: 33287921)
1. The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer.
Cabello P; Pineda B; Tormo E; Lluch A; Eroles P
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27517917
[TBL] [Abstract][Full Text] [Related]
2. How MicroRNAs Command the Battle against Cancer.
Wu HH; Leng S; Sergi C; Leng R
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892054
[TBL] [Abstract][Full Text] [Related]
3. Circular RNAs: Epigenetic regulators of PTEN expression and function in cancer.
Farazi MM; Jafarinejad-Farsangi S; Miri Karam Z; Gholizadeh M; Hadadi M; Yari A
Gene; 2024 Jul; 916():148442. PubMed ID: 38582262
[TBL] [Abstract][Full Text] [Related]
4. Genomic Characterization of
Garrido-Castro AC; Spurr LF; Hughes ME; Li YY; Cherniack AD; Kumari P; Lloyd MR; Bychkovsky B; Barroso-Sousa R; Di Lascio S; Jain E; Files J; Mohammed-Abreu A; Krevalin M; MacKichan C; Barry WT; Guo H; Xia D; Cerami E; Rollins BJ; MacConaill LE; Lindeman NI; Krop IE; Johnson BE; Wagle N; Winer EP; Dillon DA; Lin NU
Clin Cancer Res; 2021 Feb; 27(4):1105-1118. PubMed ID: 33293374
[TBL] [Abstract][Full Text] [Related]
5. BRCA Mutations and MicroRNA Expression Patterns in the Peripheral Blood of Breast Cancer Patients.
Alavanda C; Dirimtekin E; Mortoglou M; Arslan Ates E; Guney AI; Uysal-Onganer P
ACS Omega; 2024 Apr; 9(15):17217-17228. PubMed ID: 38645356
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer.
Ruiz-Manriquez LM; Villarreal-Garza C; Benavides-Aguilar JA; Torres-Copado A; Isidoro-Sánchez J; Estrada-Meza C; Arvizu-Espinosa MG; Paul S; Cuevas-Diaz Duran R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373139
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management.
Loric S; Denis JA; Desbene C; Sabbah M; Conti M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108371
[TBL] [Abstract][Full Text] [Related]
8. An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence.
Padroni L; De Marco L; Dansero L; Fiano V; Milani L; Vasapolli P; Manfredi L; Caini S; Agnoli C; Ricceri F; Sacerdote C
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835336
[TBL] [Abstract][Full Text] [Related]
9. Cancer Biomarkers in Liquid Biopsy for Early Detection of Breast Cancer: A Systematic Review.
Duque G; Manterola C; Otzen T; Arias C; Palacios D; Mora M; Galindo B; Holguín JP; Albarracín L
Clin Med Insights Oncol; 2022; 16():11795549221134831. PubMed ID: 36338263
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer.
Fan M; Shan M; Lan X; Fang X; Song D; Luo H; Wu D
Front Pharmacol; 2022; 13():1033017. PubMed ID: 36278171
[TBL] [Abstract][Full Text] [Related]
11. miR155 deficiency reduces breast tumor burden in the MMTV-PyMT mouse model.
McDonald SJ; Cranford TL; VanderVeen BN; Cardaci TD; Velázquez KT; Enos RT; Chatzistamou I; Fan D; Murphy EA
Physiol Genomics; 2022 Nov; 54(11):433-442. PubMed ID: 36121133
[TBL] [Abstract][Full Text] [Related]
12. Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma.
Li HL; Deng NH; He XS; Li YH
Biomark Res; 2022 Jul; 10(1):52. PubMed ID: 35883139
[TBL] [Abstract][Full Text] [Related]
13. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
Zhong S; Li W; Chen Z; Xu J; Zhao J
Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
Schwarzenbach H; Milde-Langosch K; Steinbach B; Müller V; Pantel K
Breast Cancer Res Treat; 2012 Aug; 134(3):933-41. PubMed ID: 22350790
[TBL] [Abstract][Full Text] [Related]
15. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
16. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.
Abadi AJ; Zarrabi A; Gholami MH; Mirzaei S; Hashemi F; Zabolian A; Entezari M; Hushmandi K; Ashrafizadeh M; Khan H; Kumar AP
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670518
[TBL] [Abstract][Full Text] [Related]
17. Regulatory role of microRNAs on PTEN signaling.
Ghafouri-Fard S; Abak A; Shoorei H; Mohaqiq M; Majidpoor J; Sayad A; Taheri M
Biomed Pharmacother; 2021 Jan; 133():110986. PubMed ID: 33166764
[TBL] [Abstract][Full Text] [Related]
18. Circulatory miRNA-155, miRNA-21 target PTEN expression and activity as a factor in breast cancer development.
Ali SA; Abdulrahman ZFA; Faraidun HN
Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):44-50. PubMed ID: 33287921
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
